Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

Background Limited therapeutic options are available for triple-negative breast cancer (TNBC), emphasizing an urgent need for more effective treatment approaches. The development of strategies by targeting tumor-associated macrophages (TAMs) to stimulate their ability of Programmed Cell Removal (PrC...

Full description

Bibliographic Details
Main Authors: Jing Chen, Bo Xu, BoLei Li, Xu Cao, Jessica Dang, Siqi Chen, E Gulsen Gunes, Lei Tian, Sabina Muend, Mustafa Raoof, Christiane Querfeld, Jianhua Yu, Steven T. Rosen, Yingyu Wang, Mingye Feng
Format: Article
Language:English
Published: BMJ Publishing Group 2021-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/3/e002022.full

Internet

https://jitc.bmj.com/content/9/3/e002022.full

Similar Items